Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $3.6 million.

  • Iradimed's Non-Current Deffered Revenue rose 3000.39% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 3000.39%. This contributed to the annual value of $3.0 million for FY2024, which is 715.0% up from last year.
  • Latest data reveals that Iradimed reported Non-Current Deffered Revenue of $3.6 million as of Q3 2025, which was up 3000.39% from $3.3 million recorded in Q2 2025.
  • Iradimed's Non-Current Deffered Revenue's 5-year high stood at $3.6 million during Q3 2025, with a 5-year trough of $1.4 million in Q4 2022.
  • Over the past 5 years, Iradimed's median Non-Current Deffered Revenue value was $2.7 million (recorded in 2024), while the average stood at $2.5 million.
  • As far as peak fluctuations go, Iradimed's Non-Current Deffered Revenue tumbled by 2982.17% in 2022, and later surged by 10313.8% in 2023.
  • Quarter analysis of 5 years shows Iradimed's Non-Current Deffered Revenue stood at $1.7 million in 2021, then dropped by 18.11% to $1.4 million in 2022, then surged by 103.14% to $2.8 million in 2023, then grew by 7.15% to $3.0 million in 2024, then increased by 19.36% to $3.6 million in 2025.
  • Its Non-Current Deffered Revenue was $3.6 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.2 million in Q1 2025.